Sophie Stocker is an Associate Professor in the Sydney Pharmacy School. She is also an Honorary Senior Hospital Scientist in the Department of Clinical Pharmacology and Toxicology at St Vincent’s Hospital, Sydney; an Adjunct Senior Lecturer of the St Vincent’s Clinical School, University of New South Wales; and an Honorary Scientist at the Garvan Medical Research Institute. Her research program involves clinical and experimental pharmacology, ethnopharmacology, pharmacogenomics, pharmacometrics and qualitative research on the impact of intrinsic and extrinsic factors on drug disposition, efficacy and safety. Her research focuses on understanding variability in response to medicines and how this can be managed to optimise patient care.

Prof Jan-Willem Alffenaar is a hospital pharmacist and clinical pharmacologist at the School of Pharmacy, Faculty of Medicine and Health at the University of Sydney. He is theme lead AMR and novel therapies of the University of Sydney Infectious Diseases Institute and member of the antimicrobial stewardship committee at Westmead Hospital. He is an internationally recognized expert in therapeutic drug monitoring and dose optimization of antimicrobial therapy. He is the current President of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. He is a member of the WHO’s Technical Advisory Group on TB drug dosing. Prof Alffenaar led systematic reviews for WHO on various antimicrobial drugs informing the WHO TB treatment policy review meeting as well as the WHO Fungal Priority Pathogen List. He has led the education on antimicrobial stewardship to pharmacy students since 2019 as well clinical auditing in Westmead Hospital. His research is focussed on personalized dosing in a programmatic setting using innovative sampling techniques and point-of-care saliva testing.